aradigm (aradigm)

aradigm

Non-Tb Mycobacteria Treatments

Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.

aradigm

Pulmonary Exacerbation

• exacerbation
• pulmonary

Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.

aradigm

Pulmonary Exacerbation

• exacerbation
• pulmonary

Oral antibiotics are regarded as the commonest means with the help of which Pulmonary Exacerbation can be thoroughly treated. These antibiotics are highly useful in destroying the infectious elements like viruses or bacteria causing this pulmonary trouble and thus you can have immediate effects.

aradigm

Cystic Fibrosis Inhaled Antibiotics

Diseases such as cystic fibrosis one require inhalers to ease out breathing problems. They get immediate relief when they use such antibiotics in the form of inhalers. Hence they are extensive used to provide relief and they are extensively known as Cystic Fibrosis Inhaled Antibiotics.

aradigm

Inhaled Liposomes

• inhaled
• liposomes

Aradigm’s liposome formulations are nano-size liquid vesicles made out of lipids that encapsulate drugs. When the drug in these vesicles is deposited in the respiratory tract, it is slowly released, with the view to provide sustained delivery of the drug at the site of action and only minimum concentration of the drug in the rest of the body. Purposeful formulations of Inhaled Liposomes can also achieve preferential targeting of drugs to certain cell types,

aradigm

Non-Cystic Fibrosis Bronchiectasis

• bronchiectasis
• fibrosis
• noncystic

Aradigm has product candidates addressing the treatment of non-cystic fibrosis bronchiectasis, cystic fibrosis and prevention of respiratory and other diseases in tobacco smokers through smoking cessation.

aradigm

Biodefense Antibiotics

• antibiotics
• biodefense

Aradigm is uniquely positioned to develop a portfolio of its own products to treat patients with severe respiratory diseases. The current pipeline includes an inhaled antibiotic being developed for the treatment of bronchiectasis, cystic fibrosis and for biodefense antibiotics, and inhaled nicotine for smoking cessation.

aradigm

Smoking Cessation

• cessation
• smoking

Smoking cessation is highly needed as it can be highly dangerous for your health. Smoking is quite an unhealthy practice that can bring different dreadful disease and can cause a great harm to your lungs.

aradigm

Pseudomonas Clinical Trials

• clinical
• pseudomonas
• trials

They generally do not cause infections in healthy people, and even if an infection does occur in a healthy person it is generally mild. Pseudomonas Clinical Trials will help individuals suffering from such get a new hope and find help to their situations.

aradigm

Non-Cystic Fibrosis Bronchiectasis

Non-Cystic Fibrosis Bronchiectasis is a lung disease but not highly risky and serious like the CF Bronchiectasis. This is an abnormal medical condition where dilated airways permanently take place that gets triggered by chronic bronchial inflammation.

aradigm

Inhaled Liposomes

• inhaled
• liposomes

Aradigm’s liposome formulations are nano-size liquid vesicles made out of lipids that encapsulate drugs. When the drug in these vesicles is deposited in the respiratory tract, it is slowly released, with the view to provide sustained delivery of the drug at the site of action and only minimum concentration of the drug in the rest of the body.

aradigm

Inhaled Insulin

AERx iDMS provide solution for diabetes patients with various techniques. Aradigm Corporation also deals with inhaled insulin products at USA.

aradigm

Chronic Lung Infections Antibiotics

• antibiotics
• chronic
• infections
• lung

This is further related to many chronic infections. The firms have had to clinical trials with pseudomonas and that includes Pulmaquin and Lipoquin from the formulations of ciprofloxacin. Here are the details of the Chronic Lung Infections Antibiotics.

aradigm

Smoking Cessation

• cessation
• smoking

Smoking Cessation is a tough process but with a strong desire to live life in a healthy way and discontinue bad habit, one can at ease overcome the initial difficulties of smoking cessation.

aradigm

Non-Cf Bronchiectasis

• bronchiectasis
• noncf

Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.

aradigm

Inhaled Nicotine

• inhaled
• nicotine

Our goal is to develop an inhaled nicotine product that would address effectively the acute craving for cigarettes and, through gradual reduction of the peak nicotine levels, wean-off the patients from cigarette smoking and from the nicotine addiction.

aradigm

Non-Cf Bronchiectasis

• bronchiectasis
• noncf

It is a medical condition that demands immediate medical attention so that patient can breathe easily. It is a disease where the lungs got infected causing difficulty in breathing. Get more information visit us at: http://www.aradigm.com/

aradigm

Non-Cystic Fibrosis Bronchiectasis

• bronchiectasis
• fibrosis
• noncystic

Guidelines to identify this particular disease have many hurdles and it takes expert doctors and number of clinical tests and examinations apart from regular monitoring. The Non-Cystic Fibrosis Bronchiectasis requires stringent diagnosis as well regular medical attention to get considerable relief from the pain.

aradigm

Cystic Fibrosis Inhaled Antibiotics

• antibiotics
• cystic
• fibrosis
• inhaled

Antibiotics are wonderful revolutionary drugs man has ever witnessed in the recent decades. It is in reality is a medicine where they are used to inhibit the growth of pathogens or harmful bacteria. They are widely used in the treatment of infections caused by viruses, for example, flu cold, and consistent cough sore throat.

aradigm

Inhaled Ciprofloxacin

• ciprofloxacin
• inhaled

Aradigm’s liposome formulations are nano-size liquid vesicles made out of lipids that encapsulate drugs. When the drug in these vesicles is deposited in the respiratory tract, it is slowly released, with the view to provide sustained delivery of the drug at the site of action and only minimum concentration of the drug in the rest of the body.